Congenital Melanocytic Nevus in Children – Diagnosis, Assessment, and Management

Diagnosis

• Congenital melanocytic nevus (CMN) is the most likely diagnosis for a brown, hypertrichotic patch present at birth or shortly thereafter. 1
• When the lesion is located over the midline spine (especially lumbosacral), it serves as a high‑risk cutaneous marker for underlying spinal dysraphism and warrants urgent neurosurgical evaluation. 3

Initial Assessment Algorithm

Location

• Midline spinal hypertrichosis mandates spinal MRI and neurosurgical consultation within days to weeks because 70 % of children with congenital spinal cord malformations exhibit cutaneous markers such as hypertrichosis, and the finding is linked to split‑cord and tethered‑cord malformations. 5
• Lesions situated off the midline should be evaluated as CMN without immediate spinal imaging. 2

Size Classification (projected adult size)

• Projected adult size is estimated by multiplying the current lesion size by 1.5–2 × for trunk lesions and by 3 × for extremity lesions. 2

Satellite Lesions

• The presence of ≥ 10 satellite nevi markedly raises the risk for neurocutaneous melanosis. 6
• More than one CMN (multiple lesions) indicates the need for MRI screening for neurocutaneous involvement. 7

Red‑Flag Features Requiring Urgent Dermatology Referral

• Rapid or asymmetric growth beyond expected proportional increase. 6
• New color variation or heterogeneous darkening. 6
• Development of deep nodules or papules (melanoma may present without surface color change). 6
• Bleeding, ulceration, or persistent erosions. 6
• Pain or marked pruritus. 6

Screening for Neurocutaneous Melanosis

• Brain and spine MRI (non‑contrast, no anesthesia in infants) is recommended when any of the following are present:
  
  • Medium‑to‑large CMN (projected adult size > 1.5 cm). 2
  • Multiple CMN or ≥ 10 satellite lesions. 6
  • Giant CMN (> 40 cm). 6
• Approximately 10 % of screened children demonstrate intraparenchymal melanosis, conferring the highest melanoma risk (up to 8 % in multiple CMN, predominantly CNS melanoma). 6

Melanoma Risk Stratification

• Overall lifetime melanoma risk for all CMN ranges from 0.7 % to 2.2 %. 2
• Giant CMN carry a 3–10 % lifetime risk, with half of melanomas arising by age 2 and 80 % by age 7. 2
• In patients with multiple CMN, the majority of melanomas develop in the central nervous system rather than the skin. 6

Surveillance Protocol

• First year: clinical review every 3 months for lesions showing growth or concerning features; include visual inspection, palpation, and serial photography. 6
• Long‑term: at minimum, annual dermatology visits for stable small‑to‑medium CMN; increase frequency to every 3–6 months for large/giant or multiple lesions. 6
• Families should be taught the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter > 6 mm, Evolution) for self‑monitoring. 2

Management

Conservative (Observation)

• Uncomplicated small and medium CMN are managed with observation alone. Expected benign evolution includes proportional growth, mottled or heterogeneous pigmentation, surface becoming raised or verrucous, increased hair growth, and gradual lightening over time. 1

Surgical Considerations

• Indications for operative intervention include functional impairment, difficulty achieving reliable clinical monitoring, significant psychosocial impact (reported by ~54 % of adolescents), or emergence of suspicious nodules/changes. 1
• Surgical options for large/giant CMN:
  
  • Serial excision.
  • Tissue expansion (reported complication rate ≈ 18.2 %).
  • Local flap reconstruction or grafting. 1

Procedures to Avoid

• Ablative modalities (laser, curettage, dermabrasion) should be avoided because they obscure future melanoma assessment, frequently lead to pigment recurrence, and do not eradicate deep melanocytes. 6
• When a biopsy is required, a complete excisional biopsy is preferred over a shave biopsy to allow full histopathologic evaluation. 6

Hair (Hypertrichosis) Management

• Infants: simple trimming is sufficient.
• Older children: shaving, waxing, threading, chemical depilation, or trimming are low‑risk options.
• Permanent reduction (laser or electrolysis) requires multiple sessions and may induce histologic changes that complicate lesion monitoring. 1

Family Counseling and Support

• Explain the natural history: many CMN lighten over time and surface changes are expected.
• Emphasize the low but real melanoma risk and the importance of diligent skin surveillance.
• Recommend standard sun‑protection measures (broad‑spectrum sunscreen, protective clothing, hats). 9
• Provide information on psychosocial support resources and patient advocacy groups.
• Caution that certain interventions (e.g., aggressive laser or extensive excision) can produce disfiguring scars, keloids, or recurrent nevi. 1

Common Pitfalls to Avoid

• Failing to palpate the lesion—deep melanoma may present without surface color change. 6
• Missing spinal dysraphism by not assessing lesion location; midline spinal hypertrichosis mandates neurosurgical work‑up. 3
• Performing ablative procedures that compromise future melanoma surveillance. 6
• Inadequate MRI screening for neurocutaneous melanosis in medium‑to‑large, multiple, or satellite‑rich CMN. 7
• Assuming all lesion growth is malignant; proportional growth with the child is typically benign. 6